Pfizer Inc. FDA Record
- Latest inspection NAI · Feb 13, 2026
- 17 Class I recalls
- Last warning letter 2012
Pfizer Inc. has 129 FDA recalls (17 Class I), 47 inspections, 30 510(k) clearances and 3 compliance actions on record. FDA has issued 3 warning letters to Pfizer Inc., the most recent on May 24, 2012. FDA has published 1 Form 483 for Pfizer Inc..
- Latest recall
- D-0052-2027 · Class II · Sep 29, 2026
- Latest inspection
- Feb 13, 2026 · NAI
- Latest 510(k)
- Sep 15, 2018
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 129 (17 Class I) | Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026 | Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026 | Current |
| 510(k) clearances | 30 | Nov 22, 2026 | File dated Nov 18, 2026 | Current |
| Inspections | 47 | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 3 | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
FDA record by year
Pfizer Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 1 | 0 | 0 | 3 | 0 |
| 2025 | 3 | 0 | 0 | 6 | 0 |
| 2024 | 0 | 0 | 0 | 2 | 0 |
| 2023 | 2 | 0 | 0 | 8 | 7 |
| 2022 | 3 | 0 | 0 | 16 | 3 |
| 2021 | 3 | 0 | 0 | 11 | 2 |
| 2020 | 0 | 0 | 0 | 7 | 0 |
| 2019 | 1 | 0 | 0 | 16 | 1 |
| 2018 | 3 | 0 | 0 | 12 | 2 |
| 2017 | 4 | 0 | 0 | 12 | 2 |
Reviewing Pfizer Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Pfizer Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Pfizer Inc. FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| May 24, 2012 · Record page | |||
| May 26, 2010 · Record page | |||
| Apr 9, 2010 · Record page |
Pfizer Inc. Form 483s
| Date | Document | FEI |
|---|---|---|
| Jul 23, 2015 · Document on fda.gov | 483 | 1876582 |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0052-2027 | Class II | Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only… | Sep 29, 2026 |
| D-0051-2027 | Class II | Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only… | Sep 29, 2026 |
| D-0853-2026 | Class II | Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only… | Sep 4, 2026 |
| D-0590-2025 | Class II | Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc… | Aug 4, 2025 |
| D-0591-2025 | Class II | Vial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc… | Aug 4, 2025 |
| D-0575-2025 | Class II | Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by… | Jul 29, 2025 |
| D-0545-2025 | Class II | Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx… | Jul 10, 2025 |
| D-0544-2025 | Class II | Bicillin L-A (penicllin G benzathine injectable suspension), 1,200,000 units per 2 mL, 2 mL-vial, Rx… | Jul 10, 2025 |
| D-0489-2025 | Class II | DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10… | May 28, 2025 |
| D-0564-2024 | Class II | Buprenorphine Hydrochloride Injection, 0.3 mg base/mL, 1 mL Single-dose Carpuject, Sterile Cartridge… | May 20, 2024 |
| D-0565-2024 | Class II | Labetalol Hydrochloride Injection, USP, 20 mg/4 mL (5 mg/mL), 4 mL Single-dose Carpuject, Sterile… | May 20, 2024 |
| D-0234-2024 | Class I | 8.4 % Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), Lifeshield, Glass ABBOJECT Unit of… | Dec 21, 2023 |
| D-0235-2024 | Class I | Atropine Sulfate Injection, USP 1 mg/10 mL (0.1 mg/mL), Lifeshield, Glass ABBOJECT Unit of Use… | Dec 21, 2023 |
| D-0261-2024 | Class I | Bleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only… | Dec 21, 2023 |
| D-0233-2024 | Class I | 4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe… | Dec 21, 2023 |
| D-0101-2024 | Class I | 1% Lidocaine HCl Injection, USP, 50mg/5mL(10mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as… | Oct 2, 2023 |
| D-0100-2024 | Class I | 4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5mEq/mL), Glass ABBOJECT Unit of Use Syringe… | Oct 2, 2023 |
| D-0102-2024 | Class I | 2% Lidocaine HCl Injection, USP, 100mg/5mL(20mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as… | Oct 2, 2023 |
| D-0532-2023 | Class III | MEKTOVI (binimetinib) tablets, 15 mg, 180-count bottle, Rx only, Distributed by: Array BioPharma… | Mar 8, 2023 |
| D-0097-2023 | Class II | Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride Injection… | Dec 29, 2022 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Feb 13, 2026 | San Diego, CA | Biologics | No Action Indicated (NAI) | 3001433984 |
| Oct 24, 2025 | Groton, CT | Drugs | Voluntary Action Indicated (VAI) | 1211022 |
| Aug 22, 2025 | San Diego, CA | Drugs | No Action Indicated (NAI) | 3001433984 |
| Jun 18, 2025 | Parsippany, NJ | Drugs | No Action Indicated (NAI) | 3003836868 |
| May 5, 2023 | San Diego, CA | Drugs | No Action Indicated (NAI) | 3001433984 |
| Apr 19, 2023 | Groton, CT | Drugs | No Action Indicated (NAI) | 1211022 |
| Oct 28, 2022 | Groton, CT | Drugs | No Action Indicated (NAI) | 1211022 |
| Sep 28, 2022 | Parsippany, NJ | Drugs | No Action Indicated (NAI) | 3003836868 |
| Jul 22, 2022 | New York, NY | Drugs | No Action Indicated (NAI) | 2416101 |
| Nov 19, 2021 | Groton, CT | Drugs | No Action Indicated (NAI) | 1211022 |
| Jun 4, 2021 | Groton, CT | Drugs | No Action Indicated (NAI) | 1211022 |
| Jan 8, 2021 | Groton, CT | Biologics | No Action Indicated (NAI) | 1211022 |
| Aug 20, 2019 | Chesterfield, MO | Drugs | No Action Indicated (NAI) | 1940118 |
| Nov 2, 2018 | Groton, CT | Drugs | No Action Indicated (NAI) | 1211022 |
| Oct 5, 2018 | Groton, CT | Drugs | No Action Indicated (NAI) | 1211022 |
| Jun 21, 2018 | Groton, CT | Drugs | Voluntary Action Indicated (VAI) | 1211022 |
| Sep 8, 2017 | Peapack, NJ | Drugs | No Action Indicated (NAI) | 3004945409 |
| Jun 28, 2017 | Groton, CT | Drugs | Voluntary Action Indicated (VAI) | 1211022 |
| Jun 7, 2017 | Groton, CT | Drugs | Voluntary Action Indicated (VAI) | 1211022 |
| Jan 12, 2017 | Groton, CT | Drugs | No Action Indicated (NAI) | 1211022 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 3 compliance actions under Pfizer Inc.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3001433984 | San Diego, CA | 3 | Feb 13, 2026 |
| FEI 1211022 | Groton, CT | 22 | Oct 24, 2025 |
| FEI 3003836868 | Parsippany, NJ | 5 | Jun 18, 2025 |
| FEI 2416101 | New York, NY | 5 | Jul 22, 2022 |
| FEI 1940118 | Chesterfield, MO | 4 | Aug 20, 2019 |
| FEI 3004945409 | Peapack, NJ | 3 | Sep 8, 2017 |
| FEI 3005078489 | Cary, NC | 2 | Aug 25, 2011 |
| FEI 1819598 | Terre Haute, IN | 2 | Jun 24, 2010 |
| FEI 2410924 | Brooklyn, NY | 1 | Oct 1, 2008 |
Recent 510(k) clearances
| K-Number | Device | Date |
|---|---|---|
| K181102 | ThermaCare Quick Therapy TENS | Sep 15, 2018 |
| K991620 | VISINE FOR CONTACTS | Sep 24, 1999 |
| K892264 | ORALCHEK SUPER-SOFT BRUSH | Jun 14, 1989 |
| K892360 | WATER JEL STERILE GEL-SOAKED BURN DRESSING | Jun 5, 1989 |
| K881378 | PFIZER HOSPITAL PRODUCTS GROUP ACL DRILL GUIDE | Jun 17, 1988 |
| K854726 | MEDI-WIPES UNITED ANTISEPTIC SKIN PREP | Feb 24, 1986 |
| K850443 | MEC ROD CONNECTOR | Jul 15, 1985 |
| K850840 | HOWMEDICA THREADED ACETABULAR COMPONENT | Jul 15, 1985 |
| K850413 | MEC HIP BOLT | Jul 15, 1985 |
| K850403 | MEC DISTAL FEMORAL BOLT | Jul 15, 1985 |
| K851971 | SERIES 7000/HOLTER RECORDER | Jun 20, 1985 |
| K852041 | DEKNATEL THORACIC CATHETER | Jun 17, 1985 |
| K851024 | PLEUR-EVAC AUTOTRANSFUSION SYSTEM -TENTATIVE | May 23, 1985 |
| K850441 | MEC INTRAMEDULLARY ROD | Apr 19, 1985 |
| K850886 | COMPRESSION HIP SCREW SYSTEM | Apr 19, 1985 |
| K850401 | LETOURNEL ACETABULAR PLATE | Apr 19, 1985 |
| K850444 | MEC BUTRESS PLATE | Apr 19, 1985 |
| K850442 | MEC BROAD BONE PLATE | Apr 19, 1985 |
| K844938 | UNITED SKIN BARRIERS | Jan 18, 1985 |
| K792349 | SUSCEPTIBILITY DISK, CINOXACIN 100 MCG. | Mar 12, 1980 |
Pfizer Inc. and the FDA: common questions
Has Pfizer Inc. received an FDA warning letter?
Yes. FDA has issued 3 warning letters to Pfizer Inc.. The most recent is dated May 24, 2012.
Has Pfizer Inc. received an FDA Form 483?
FDA has published 1 Form 483 for Pfizer Inc. in its reading room, the most recent dated Jul 23, 2015. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Pfizer Inc.?
The most recent FDA inspection on file ended Feb 13, 2026 at San Diego, CA and was classified NAI. FDA has 47 inspections of Pfizer Inc. on file, 2 of them classified OAI (official action indicated).
Has Pfizer Inc. had an FDA recall?
Yes. Pfizer Inc. has 129 FDA recalls on record, 17 of them Class I, the most serious class. The most recent started Sep 29, 2026.
Need more than this page shows? Ask about Pfizer Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.